Pharmafile Logo
Pharmafocus logo
Advanced Search

GSK

Showing 15 posts of 760 posts found.

Lonza wins contract for Genmab/GSK’s Arzerra

November 12, 2009
Manufacturing and Production GSK, Lonza

 Swiss contract manufacturer Lonza will manufacture a newly-approved treatment for chronic lymphocytic leukaemia after signing a deal with Genmab and …

News

GlaxoSmithKline-Pfizer launch HIV joint venture

November 4, 2009
Research and Development, Sales and Marketing GSK, HIV, Pfizer, ViiV

GlaxoSmithKline and Pfizer have launched a specialist HIV company with access to ten medicines developed by the two manufacturers.ViiV Healthcare, …

News

Phase III success for GSK’s lupus drug

November 3, 2009
Research and Development, Sales and Marketing Benlysta, GSK

 GlaxoSmithKline’s lupus drug Benlysta has been successful in the second of two phase III trials, following earlier performance that exceeded …

News

GSK returns to growth despite US sales hit

October 28, 2009
Sales and Marketing GSK, generics

GlaxoSmithKline suffered a hit in the US during the third quarter of the year, with sales down 12% to £2.14 …

News

GSK begins phase III COPD trials

October 28, 2009
Research and Development, Sales and Marketing COPD, GSK, GlaxoSmithKline, Seretide, Theravance, resp, respiratory

GlaxoSmithKline and San Francisco biopharma firm Theravance have begun a phase III trial to develop a new treatment for chronic …

News

GSK kidney cancer drug approved in US

October 20, 2009
Research and Development, Sales and Marketing Cancer, GSK, rcc

 GlaxoSmithKline’s Votrient has been approved in the US by the FDA to treat the most common form of kidney cancer.This …

News

GSK’s Cervarix finally wins US approval

October 19, 2009
Sales and Marketing Cervarix, GSK, US

US regulator the FDA has approved GlaxoSmithKline's cervical cancer vaccine Cervarix, finally allowing the company to bring it to the …

News

GSK plans

October 14, 2009
Research and Development GSK

GlaxoSmithKline, the government and the Wellcome Trust are collaborating to build what they hope will be a "world-class" science park. …

News

GSK’s Avodart tackles BPH better in combination

October 14, 2009
Research and Development, Sales and Marketing GSK, bph, urology

GlaxoSmithKline's urinary treatment Avodart works better as part of a combination therapy, according to a new survey. The drug was …

News

GSK expands in China with vaccine joint venture

October 12, 2009
Sales and Marketing China, GSK, vaccines

GSK has joined with Chinese biotech Jiangsu Walvax to develop and manufacture paediatric vaccines for use in China.The pair will …

News
GSK patient page

Digital Pharma: GSK pushes patient information boundaries

October 12, 2009
Medical Communications GSK, digi, digital pharma, patient information

GlaxoSmithKline has launched a product information website for patients in the UK, becoming the second major pharma company to push …

Feature

GSK agrees more government orders for H1N1 vaccine

October 7, 2009
Sales and Marketing GSK, h1n1, vaccines

GSK has agreed another 22 government orders for its adjuvanted swine-flu vaccine – an extra 149 million doses on top …

News

GSK: Committed to improving UK clinical research

October 6, 2009
Research and Development GSK, GlaxoSmithKline, NHS

GSK is the second biggest pharma company in the world, and Britain’s biggest homegrown firm in the sector. That means …

Feature

Europe approves two swine-flu vaccines

September 30, 2009
Sales and Marketing EU, GSK, Novartis, h1n1

The European Commission has approved the use of two vaccines for the pandemic H1N1 virus, commonly known as swine flu. …

News

GSK faces fresh US delays over Cervarix

September 30, 2009
Sales and Marketing Cervarix, GSK, vaccines

GSK faces new delays in the US over the approval of its cervical cancer vaccine Cervarix, after the FDA failed …

News
The Gateway to Local Adoption Series

Latest content

Rhythm AI’s STAR Apollo system receives FDA clearance for atrial fibrillation

February 12, 2026

iOrganBio appoints Karol Jarzabek as Chief Operating Officer

February 12, 2026

Ensera Design expands UK leadership team with new senior appointments

February 11, 2026

Infinitopes announces $15.4m in additional seed funding to advance cancer vaccine

February 11, 2026

Angelini Pharma appoints Roberto Scrivo as Chief of External Affairs, Communication and Sustainability Officer

February 10, 2026